+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Doxepin"

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026 - Product Thumbnail Image

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026

  • Report
  • February 2021
  • 420 Pages
  • United States
From
Insomnia - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Insomnia - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • February 2023
  • 198 Pages
  • Global
From
From
From
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Doxepin is a tricyclic antidepressant used to treat depression, anxiety, and insomnia. It is classified as a central nervous system (CNS) drug, and is one of the most commonly prescribed antidepressants in the United States. Doxepin works by blocking the reuptake of serotonin and norepinephrine, two neurotransmitters that are involved in regulating mood. It is available in both oral and topical forms, and is often used in combination with other medications to treat depression. Doxepin is generally well-tolerated, but can cause side effects such as dry mouth, drowsiness, and blurred vision. It is important to discuss any potential risks with a healthcare provider before taking doxepin. The doxepin market is highly competitive, with many pharmaceutical companies offering generic and branded versions of the drug. Some of the major players in the market include Pfizer, Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more